Obstet Gynecol Sci.  2017 Jul;60(4):369-373. 10.5468/ogs.2017.60.4.369.

Primary mucinous adenocarcinoma of the vulva, intestinal type

Affiliations
  • 1Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea. 1103khl@hanmail.net
  • 2Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea.

Abstract

Primary vulva malignancy is a rare gynecologic malignancy. Most of them are squamous cell carcinomas and adenocarcinomas are much less common. Intestinal type is a rare variant of primary adenocarcinoma of the vulva. It histologically resembles mucinous colonic carcinomas. Origin from cloacal remnants has been suggested but remains speculative. A 64-year-old woman was referred to our clinic with a 1-month history of an itching vulva mass. An incisional biopsy was performed at other hospital and disclosed adenocarcinoma of intestinal type. Extensive workups were performed to detect other underlying carcinomas but revealed nothing abnormal. She underwent wide local excision without lymph node dissection for a primary vulva carcinoma. She received no adjuvant therapy and has been free from recurrent disease for 12 months after surgery. The authors report a rare case and review the relevant literature.

Keyword

Adenocarcinoma, mucinous; Intestinal type; Vulva neoplasms

MeSH Terms

Adenocarcinoma
Adenocarcinoma, Mucinous*
Biopsy
Carcinoma, Squamous Cell
Colon
Female
Humans
Lymph Node Excision
Middle Aged
Mucins*
Pruritus
Vulva*
Vulvar Neoplasms
Mucins

Figure

  • Fig. 1 (A) The vulva reveals a reddish dome-like cutaneous mass. (B) The tumor shows an infiltrative mucinous carcinoma and predominant mucin pools. (C) The mucinous carcinoma is intestinal types with presence of characteristically colonic goblet cells (inset) and intracytoplasmic mucin. (D) On immunohistochemical staining the tumor cells show diffuse positive reaction for CEA, (E) cytokeratin 20, and (F) cytokeratin 7.


Reference

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006; 56:106–130.
2. Ghamande SA, Kasznica J, Griffiths CT, Finkler NJ, Hamid AM. Mucinous adenocarcinomas of the vulva. Gynecol Oncol. 1995; 57:117–120.
3. Lulenski CR, Naji AF. Mucin-secreting adenocarcinoma of Bartholin gland: report of a case. Obstet Gynecol. 1964; 24:542–544.
4. Cormio G, Carriero C, Loizzi V, Gissi F, Leone L, Putignano G, et al. “Intestinal-type” mucinous adenocarcinoma of the vulva: a report of two cases. Eur J Gynaecol Oncol. 2012; 33:433–435.
5. Tiltman AJ, Knutzen VK. Primary adenocarcinoma of the vulva originating in misplaced cloacal tissue. Obstet Gynecol. 1978; 51:30s–33s.
6. Kennedy JC, Majmudar B. Primary adenocarcinoma of the vulva, possibly cloacogenic: a report of two cases. J Reprod Med. 1993; 38:113–116.
7. Willen R, Bekassy , Carlen B, Bozoky B, Cajander S. Cloacogenic adenocarcinoma of the vulva. Gynecol Oncol. 1999; 74:298–301.
8. Zaidi SN, Conner MG. Primary vulvar adenocarcinoma of cloacogenic origin. South Med J. 2001; 94:744–746.
9. Rodriguez A, Isaac MA, Hidalgo E, Marquez B, Nogales FF. Villoglandular adenocarcinoma of the vulva. Gynecol Oncol. 2001; 83:409–411.
10. Dube V, Veilleux C, Plante M, Tetu B. Primary villoglandular adenocarcinoma of cloacogenic origin of the vulva. Hum Pathol. 2004; 35:377–379.
11. Sui Y, Zou J, Batchu N, Lv S, Sun C, DU J, et al. Primary mucinous adenocarcinoma of the vulva: a case report and review of the literature. Mol Clin Oncol. 2016; 4:545–548.
12. Dehner LP. Metastatic and secondary tumors of the vulva. Obstet Gynecol. 1973; 42:47–57.
13. Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Leuchter RS. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol. 1984; 63:155–162.
Full Text Links
  • OGS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr